跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 662 条关于
“pertuzumab-dpzb”
全部
662
临床试验
523
药物
49
机构
0
资讯
90
10个月前
FDA Approves First Interchangeable Biosimilar to Pertuzumab for HER2-Positive Breast Cancer
10个月前
FDA Approves First Perjeta Biosimilar as Shanghai Henlius and Organon Secure Interchangeable Status
9个月前
FDA Approves Wave of Oncology Drugs and Biosimilars in November 2025, Expanding Treatment Access
去年
Genentech Initiates First Patent Litigation Against Pertuzumab Biosimilar HLX11
去年
Trastuzumab/Pertuzumab Shows Promise for HER2-Positive Metastatic Colorectal Cancer
去年
Trastuzumab Biosimilar Plus Pertuzumab Shows Efficacy in HER2-Positive Breast Cancer
6年前
Pertuzumab Regimen Shows Modest Survival Benefit in HER2-Positive Early Breast Cancer
12个月前
Enzene Launches Commercial Supply of Pertuzumab Biosimilar Using Continuous Manufacturing Technology
12个月前
Alkem Laboratories Launches Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer in India
去年
FDA Reviews Pertuzumab Biosimilar HLX11 for HER2-Positive Breast Cancer Treatment
第 1 页,共 9 页
上一页
下一页